Body Vision Medical has closed a new round of funding to capitalize on the rising demand for advanced imaging technology used to support the diagnosis and treatment of early-stage lung diseases. The round was led by Business Asia Consultants, Inc. (BAC), a U.S. corporation, and Sprim Global Investments, headquartered in Singapore.

Body Vision Medical believes in saving lives through the globalization of innovative medical technology. LungVision® provides AI-powered real-time image guidance to address the clinical need for early, definitive lung cancer diagnosis and to enable localized treatment of lung lesions via minimally invasive procedures.